Editorial Comment on: Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers

European Urology

Volumn 56, Issue 3, 2009, Pages 542-543

  Speakman, Mark J ^a  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TOLTERODINE; BENZHYDRYL DERIVATIVE; CRESOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE;

ARTICLE; HUMAN; INCIDENCE; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; OVERACTIVE BLADDER; PRIORITY JOURNAL; RESIDUAL URINE; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; URGE INCONTINENCE; URINE RETENTION; DRUG COMBINATION; NOTE; PROSTATISM;

ADRENERGIC ALPHA-ANTAGONISTS; BENZHYDRYL COMPOUNDS; CRESOLS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; PROSTATISM; URINARY BLADDER, OVERACTIVE;

EID: 67651042773     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.11.028     Document Type: Note

References (3)

1. Athanasopulos A., Gyftopoulos K., Giannitsas K., et al. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective randomised controlled trial. J Urol 169 (2003) 2253-2256
2. Kaplan S.A., Roehrborn C.G., Rovner E.S., et al. Toletrodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296 (2006) 2319-2328
3. Chapple C., Herschorn S., Abrams P., et al. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α-blockers. Eur Urol 56 (2009) 534-543